Back to today’s briefing

Story perspectives

Federal Judge Pauses Case, Urges FDA Review of Mifepristone

4/8/2026

50 8 Full Breakdown

Summary

Story summary

Judge David Joseph, a federal judge in Louisiana, ordered the Food and Drug Administration (FDA) to report on its review of mifepristone and paused the state's case against the agency.
He urged action and warned that if the FDA does not complete its review, he may restrict access to the abortion pill.
A separate ruling orders the University of Pennsylvania to provide lists of Jewish employees to the Equal Employment Opportunity Commission (EEOC).

History

Historical Context

The 1973 U.S. Supreme Court decision in Roe v. Wade legalized abortion nationwide, affirming a woman's right to choose during the first trimester. This ruling sparked ongoing legal disputes, culminating in the 2022 Dobbs v. Jackson Women's Health Organization case, which overturned Roe. The current legal battles, such as the one in Louisiana, highlight the persistent tensions surrounding reproductive rights and access to abortion medications.

1 of 2

Story summary

Judge David Joseph, a federal judge in Louisiana, ordered the Food and Drug Administration (FDA) to report on its review of mifepristone and paused the state's case against the agency.
He urged action and warned that if the FDA does not complete its review, he may restrict access to the abortion pill.
A separate ruling orders the University of Pennsylvania to provide lists of Jewish employees to the Equal Employment Opportunity Commission (EEOC).

1 / 2